You are here

P T. 2012;37(3): 186-187, 189
Meeting Highlights

Cardiovascular Research Technologies 2012

Walter Alexander

From February 4–7, 2012, in Washington, D.C., the Cardiovascular Research Technologies 2012 meeting brought together 1,500 cardiologists for a varied program on advances and changes in the field of cardiovascular medicine, with an emphasis on catheter-based therapies. This year, with the recent approvals of prasugrel and ticagrelor, and with clopidogrel going off-patent, interest in the use of adenosine diphosphate P2Y12 receptor antagonists for acute myocardial infarction (AMI) and acute coronary syndrome (ACS) was particularly strong. This article reviews three presentations examining aspects of antiplatelet therapy relevant to cardiac catheter laboratory practitioners. These three topics were presented at a session entitled “ACS & AMI Management.”